Advanced chronic kidney disease is associated with myocardial fibrosis characterized by increased trimeric collagen type I and an elevated collagen type I:III ratio compared to healthy controls.
Cross-Sectional (n=43)
Myocardial fibrosis in advanced CKD is characterized by a unique molecular phenotype driven by mineral stressors, featuring increased trimeric collagen type I and dysregulated collagen metabolism.
p-value: p=<0.05
Key Points Myocardial fibrosis in hearts from patients with CKD is characterized by increased trimeric tensile collagen type I and decreased elastic collagen type III compared with hearts from hypertensive or healthy donors, suggesting a unique fibrotic phenotype. Myocardial fibrosis in CKD is driven by alterations in extracellular matrix proteostasis, including dysregulation of metalloproteinases and cross-linking enzymes. CKD-associated mineral stressors uniquely induce a fibronectin-independent mechanism of fibrillogenesis characterized by formation of trimeric collagen compared with proinflammatory/fibrotic cytokines. Background Myocardial fibrosis is a major life-limiting problem in CKD. Despite this, the molecular phenotype and metabolism of collagen fibrillogenesis in fibrotic hearts of patients with advanced CKD have been largely unstudied. Methods We analyzed explanted human left ventricular (LV) heart tissues in a three-arm cross-sectional cohort study of deceased donor patients on hemodialysis (HD, n =18), hypertension with preserved renal function (HTN, n =8), and healthy controls (CON, n =17), ex vivo . RNA-seq and protein analysis was performed on human donor hearts and cardiac fibroblasts treated with mineral stressors (high phosphate and high calcium). Further mechanistic studies were performed using primary cardiac fibroblasts, in vitro treated with mineral stressors, proinflammatory and profibrotic cytokines. Results Of the 43 donor participants, there was no difference in age ( P > 0.2), sex ( P > 0.8), or body mass index ( P > 0.1) between the groups. Hearts from the HD group had extensive fibrosis ( P < 0.01). All LV tissues expressed only the trimeric form of collagen type I. HD hearts expressed increased collagen type I ( P < 0.03), elevated collagen type I:III ratio ( P < 0.05), and decreased MMP1 ( P < 0.05) and MMP2 ( P < 0.05). RNA-seq revealed no significant differential gene expression of extracellular matrix proteins of interest in HD hearts, but there was significant upregulation of LH2, periostin, α -SMA, and TGF- β 1 gene expression in mineral stressor–treated cardiac fibroblasts. Both mineral stressors ( P < 0.009) and cytokines ( P < 0.03) increased collagen type I:III ratio. Mineral stressors induced trimeric collagen type I, but cytokine treatment induced only dimeric collagen type I in cardiac fibroblasts. Mineral stressors downregulated fibronectin ( P < 0.03) and MMP2 zymogen ( P < 0.01) but did not significantly affect expression of periostin, MMP1, or cross-linking enzymes. TGF- β upregulated fibronectin ( P < 0.01) and periostin ( P < 0.02) only. Conclusions Myocardial fibrosis in advanced CKD hearts is characterized by increased trimeric collagen type I and dysregulated collagen metabolism, and is differentially regulated by components of uremia.
Narayanan et al. (Fri,) conducted a cross-sectional in Advanced Chronic Kidney Disease (n=43). Advanced CKD (Hemodialysis) vs. Healthy controls and Hypertension was evaluated on Collagen type I:III ratio (p=<0.05). Advanced chronic kidney disease is associated with myocardial fibrosis characterized by increased trimeric collagen type I and an elevated collagen type I:III ratio compared to healthy controls.